Garcia Fernando A, Vandiver Michael W
Just Biotherapeutics, Inc.
PDA J Pharm Sci Technol. 2017 May-Jun;71(3):189-205. doi: 10.5731/pdajpst.2016.006882. Epub 2016 Dec 14.
In order to operate profitably under different product demand scenarios, biopharmaceutical companies must design their facilities with mass output flexibility in mind. Traditional biologics manufacturing technologies pose operational challenges in this regard due to their high costs and slow equipment turnaround times, restricting the types of products and mass quantities that can be processed. Modern plant design, however, has facilitated the development of lean and efficient bioprocessing facilities through footprint reduction and adoption of disposable and continuous manufacturing technologies. These development efforts have proven to be crucial in seeking to drastically reduce the high costs typically associated with the manufacturing of recombinant proteins. In this work, mathematical modeling is used to optimize annual production schedules for a single-product commercial facility operating with a continuous upstream and discrete batch downstream platform. Utilizing cell culture duration and volumetric productivity as process variables in the model, and annual plant throughput as the optimization objective, 3-D surface plots are created to understand the effect of process and facility design on expected mass output. The model shows that once a plant has been fully debottlenecked it is capable of processing well over a metric ton of product per year. Moreover, the analysis helped to uncover a major limiting constraint on plant performance, the stability of the neutralized viral inactivated pool, which may indicate that this should be a focus of attention during future process development efforts. Biopharmaceutical process modeling can be used to design and optimize manufacturing facilities and help companies achieve a predetermined set of goals. One way to perform optimization is by making the most efficient use of process equipment in order to minimize the expenditure of capital, labor and plant resources. To that end, this paper introduces a novel mathematical algorithm used to determine the most optimal equipment scheduling configuration that maximizes the mass output for a facility producing a single product. The paper also illustrates how different scheduling arrangements can have a profound impact on the availability of plant resources, and identifies limiting constraints on the plant design. In addition, simulation data is presented using visualization techniques that aid in the interpretation of the scientific concepts discussed.
为了在不同的产品需求场景下实现盈利运营,生物制药公司在设计其设施时必须考虑大规模生产的灵活性。传统生物制品制造技术由于成本高昂且设备周转时间长,在这方面带来了运营挑战,限制了可加工的产品类型和批量。然而,现代工厂设计通过减少占地面积以及采用一次性和连续制造技术,推动了精益高效生物加工设施的发展。这些开发工作已证明对于大幅降低重组蛋白制造通常涉及的高成本至关重要。在这项工作中,数学建模用于优化一个采用连续上游和离散批次下游平台运行的单产品商业设施的年度生产计划。利用细胞培养持续时间和体积生产率作为模型中的过程变量,并将年度工厂产量作为优化目标,创建三维表面图以了解过程和设施设计对预期大规模产量的影响。该模型表明,一旦工厂完全消除瓶颈,每年能够加工超过一吨的产品。此外,分析有助于发现对工厂性能的一个主要限制因素,即中和病毒灭活池的稳定性,这可能表明在未来的工艺开发工作中应将其作为关注重点。生物制药过程建模可用于设计和优化制造设施,并帮助公司实现预定的一系列目标。进行优化的一种方法是最有效地利用工艺设备,以尽量减少资本、劳动力和工厂资源的支出。为此,本文介绍了一种新颖的数学算法,用于确定最优化的设备调度配置,以使生产单一产品的设施的大规模产量最大化。本文还说明了不同的调度安排如何对工厂资源的可用性产生深远影响,并确定工厂设计的限制因素。此外,使用可视化技术展示模拟数据,有助于解释所讨论的科学概念。